DOCK9 Antibody
Novus Biologicals, part of Bio-Techne | Catalog # NB500-263
Key Product Details
Validated by
Independent Antibodies
Species Reactivity
Human
Applications
Immunoprecipitation, Western Blot
Label
Unconjugated
Antibody Source
Polyclonal Rabbit IgG
Concentration
0.2 mg/ml
Product Specifications
Immunogen
The immunogen recognized by this antibody maps to a region between residues 1 and 50 of human Dedicator of Cytokinesis 9 using the numbering given in entry NP_056111.1 (GeneID 23348).
Localization
Cytoplasmic (membrane associated)
Clonality
Polyclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for DOCK9 Antibody
Applications for DOCK9 Antibody
Application
Recommended Usage
Immunoprecipitation
2-5 ug/mg lysate
Western Blot
1:5000-1:15000
Application Notes
NB 500-263 may be used for immunoprecipitation and Western Blot. Other applications have not been tested. Suggested working dilutions: * Western Blot: 1:5,000-1:15,000. Immunoprecipitation: 2 to 5 ug/mg lysate. *The investigator should determine the optimal working dilution for a specific application.
Formulation, Preparation, and Storage
Purification
Immunogen affinity purified
Formulation
TBS and 0.1% BSA
Preservative
0.09% Sodium Azide
Concentration
0.2 mg/ml
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C. Do not freeze.
Background: DOCK9
Alternate Names
Cdc42 guanine nucleotide exchange factor zizimin-1, dedicator of cytokinesis 9, dedicator of cytokinesis protein 9, DKFZp686C11110, DKFZp686D2047, DKFZp686N04132, FLJ11949, FLJ16744, FLJ45601, KIAA1058FLJ44528, KIAA1085, ZIZ1FLJ45282, ZIZIMIN1
Entrez Gene IDs
23348 (Human)
Gene Symbol
DOCK9
UniProt
Additional DOCK9 Products
Product Documents for DOCK9 Antibody
Product Specific Notices for DOCK9 Antibody
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...